日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) for Patients with Lung Tumors and Severe Pulmonary Disease

针对肺部肿瘤和严重肺部疾病患者的个性化超分割立体定向自适应放射治疗（PULSAR）

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm15031261
Westover, Kenneth D; Li, Ruiqi; Tanner, Stetler; Aliru, Maureen; Lin, Mu-Han; Cai, Bin; Parsons, David; Visak, Justin; Gonzalez, Yesenia; Gill, Anundip; Zhang, Yuanyuan; Badiyan, Shahed N; Iyengar, Puneeth; Timmerman, Robert
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Beyond First-Generation KRAS Inhibitors: BBO-8520 Tests the Dual Mechanism Hypothesis

超越第一代KRAS抑制剂：BBO-8520检验双重机制假说

期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-24-1885
Zhou, Zhiwei; Westover, Kenneth D
RAS
发表日期：2025
文献求助 收藏

Osimertinib plus consolidative radiotherapy for advanced EGFR mutant non-small cell lung cancer: a multicentre, single-arm, phase 2 trial

奥希替尼联合巩固性放疗治疗晚期 EGFR 突变型非小细胞肺癌：一项多中心、单臂 II 期试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103435
Sampath, Sagus; Rashdan, Sawsan; Iyengar, Puneeth; Mickel, Townes A; Zhang, Song; Ahn, Chul; Gao, Ang; Dowell, Jonathan E; Zhang, Yuanyuan; Westover, Kenneth D; Cole, Suzanne M; Amini, Arya; Rock, Adam; Massarelli, Erminia; Koczywas, Marianna; Gerber, David E
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report

关于PD-L1未选择的III期非小细胞肺癌患者接受同步及巩固性度伐利尤单抗联合胸部放疗的安全性和有效性：简要报告

期刊:International Journal of Radiation Oncology Biology Physics
影响因子:6.5
doi:10.1016/j.ijrobp.2024.07.2333
Zhang, Yuanyuan; Iyengar, Puneeth; Montalvo, Steven; Westover, Kenneth D; Rashdan, Sawsan; Donthireddy, Kavitha; Kim, James; Dowell, Jonathan E; Drapkin, Benjamin; Bhalla, Sheena; Chukwuma, Christian; Nadeem, Urooba; Ahn, Chul; Timmerman, Robert D; Gerber, David E
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
发表日期：2025
文献求助 收藏

Advances and Challenges in RAS Signaling Targeted Therapy in Leukemia

白血病 RAS 信号通路靶向治疗的进展与挑战

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-24-0504
Chen, Yu; Yin, Zhenghao; Westover, Kenneth D; Zhou, Zhiwei; Shu, Liping
白血病
信号转导
RAS
发表日期：2025
文献求助 收藏

A Computational Workflow for Structure-Guided Design of Potent and Selective Kinase Peptide Substrates.

基于结构导向的高效选择性激酶肽底物设计的计算工作流程

期刊:
影响因子:
doi:10.1101/2025.07.04.663216
Yekeen Abeeb A, Meyer Cynthia J, McCoy Melissa, Posner Bruce, Westover Kenneth D
免疫/内分泌
发表日期：2025
文献求助 收藏

Experimental variables determine the outcome of RAS-RAS interactions.

实验变量决定了 RAS-RAS 相互作用的结果

期刊:Journal of Biological Chemistry
影响因子:3.9
doi:10.1016/j.jbc.2024.107859
Zhou Zhiwei, Nguyen Tra Ly, Li Xingxiao, Poujol Christel, Berlinska Ewa, Michelina Sandra Vietti, Kapp Jonas N, Plückthun Andreas, Winslow Monte M, Ambrogio Chiara, Shan Yibing, Santamaría David, Westover Kenneth D
RAS
发表日期：2024
文献求助 收藏

LIMS-Kinase provides sensitive and generalizable label-free in vitro measurement of kinase activity using mass spectrometry

LIMS-Kinase 利用质谱技术，提供了一种灵敏且通用的无标记体外激酶活性测量方法。

期刊:Cell Reports Physical Science
影响因子:7.3
doi:10.1016/j.xcrp.2023.101599
Meyer, Cynthia; McCoy, Melissa; Li, Lianbo; Posner, Bruce; Westover, Kenneth D
信号转导
多发性硬化症
发表日期：2023
文献求助 收藏

Thermal Shift Assay for Small GTPase Stability Screening: Evaluation and Suitability

用于小GTP酶稳定性筛选的热位移分析：评估和适用性

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms23137095
Kopra, Kari; Valtonen, Salla; Mahran, Randa; Kapp, Jonas N; Hassan, Nazia; Gillette, William; Dennis, Bryce; Li, Lianbo; Westover, Kenneth D; Plückthun, Andreas; Härmä, Harri
发表日期：2022
文献求助 收藏

Acid-Catalyzed Synthesis of Isatoic Anhydride-8-Secondary Amides Enables IASA Transformations for Medicinal Chemistry

酸催化合成异靛酸酐-8-仲酰胺可实现IASA转化用于药物化学

期刊:Journal of Organic Chemistry
影响因子:3.6
doi:10.1021/acs.joc.1c02036
Gondi, Sudershan R; Shaik, Althaf; Westover, Kenneth D
发表日期：2022
文献求助 收藏